Download Files:
Products Details
Product Description
– Zerlasiran is an apolipoprotein A (ApoA) synthesis reducer[1].
Web ID
– HY-147425
Shipping
– Room temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C443H594F12N144O277P40S10
References
– [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
CAS Number
– 2646703-64-0
Molecular Weight
– 14155.81
SMILES
– [Zerlasiran]
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease
Solubility
– 10 mM in DMSO
Target
– Small Interfering RNA (siRNA)
Pathway
– Epigenetics
Product type
– Oligonucleotides
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.
